These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
274 related items for PubMed ID: 3530367
1. Low molecular weight heparin plus dihydroergotamine for prophylaxis of postoperative deep vein thrombosis. Sasahara AA, Koppenhagen K, Häring R, Welzel D, Wolf H. Br J Surg; 1986 Sep; 73(9):697-700. PubMed ID: 3530367 [Abstract] [Full Text] [Related]
2. A fixed-dose combination of low molecular weight heparin with dihydroergotamine versus adjusted-dose unfractionated heparin in the prevention of deep-vein thrombosis after total hip replacement. Horbach T, Wolf H, Michaelis HC, Wagner W, Hoffmann A, Schmidt A, Beck H. Thromb Haemost; 1996 Feb; 75(2):246-50. PubMed ID: 8815569 [Abstract] [Full Text] [Related]
3. Fixed combinations of low-molecular weight or unfractionated heparin plus dihydroergotamine in the prevention of postoperative deep vein thrombosis. Kakkar VV, Stringer MD, Hedges AR, Parker CJ, Welzel D, Ward VP, Sanderson RM, Cooper D, Kakkar S. Am J Surg; 1989 Apr; 157(4):413-8. PubMed ID: 2539025 [Abstract] [Full Text] [Related]
4. Prevention of deep vein thrombosis in neurosurgical patients: a prospective double-blind comparison of two prophylactic regimen. Voth D, Schwarz M, Hahn K, Dei-Anang K, al Butmeh S, Wolf H. Neurosurg Rev; 1992 Apr; 15(4):289-94. PubMed ID: 1336131 [Abstract] [Full Text] [Related]
5. Prevention of postoperative deep vein thrombosis by one daily injection of low molecular weight heparin and dihydroergotamine. Baumgartner A, Jacot N, Moser G, Krähenbühl B. Vasa; 1989 Apr; 18(2):152-6. PubMed ID: 2545054 [Abstract] [Full Text] [Related]
6. Dihydroergotamine-heparin prophylaxis of postoperative deep vein thrombosis. A multicenter trial. The Multicenter Trial Committee. JAMA; 1984 Jun 08; 251(22):2960-6. PubMed ID: 6371278 [Abstract] [Full Text] [Related]
14. [Effectiveness and side effects of low-molecular weight heparin-dihydroergotamine in preventing thromboembolism in abdominal surgery]. Voigt J, Hamelmann H, Hedderich J, Seifert J, Buchhammer T, Köhler A. Zentralbl Chir; 1986 Jul 05; 111(21):1269-305. PubMed ID: 3544605 [Abstract] [Full Text] [Related]
15. Comparison of a low molecular weight heparin and unfractionated heparin for the prevention of deep vein thrombosis in patients undergoing abdominal surgery. The European Fraxiparin Study (EFS) Group. Br J Surg; 1988 Nov 05; 75(11):1058-63. PubMed ID: 2905187 [Abstract] [Full Text] [Related]
16. The use of dihydroergotamine and heparin in the prophylaxis of deep venous thrombosis. Comerota AJ, White JV. Chest; 1986 May 05; 89(5 Suppl):389S-395S. PubMed ID: 3698718 [Abstract] [Full Text] [Related]
18. Prophylaxis of deep vein thrombosis after major abdominal surgery. Comparison between dihydroergotamine-heparin and intermittent pneumatic calf compression and evaluation of added graduated static compression. Mellbring G, Palmér K. Acta Chir Scand; 1986 Oct 05; 152():597-600. PubMed ID: 3544626 [Abstract] [Full Text] [Related]
19. [Different effectiveness of two preparations of low molecular weight heparin in patients with elective hip joint replacement]. Weber U, Koppenhagen K, Mälzer H, Matthes M. Langenbecks Arch Chir; 1991 Oct 05; 376(3):147-51. PubMed ID: 1651434 [Abstract] [Full Text] [Related]